Pharmaceuticals

Albumin Excipient Market Forecast 2025–2034: Where Businesses Should Invest Next

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Albumin Excipient Market Between 2025 And 2029?

The albumin excipient market has experienced significant growth over recent years. It is projected to expand from $4.85 billion in 2024 to $5.15 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historical growth can be attributed to the expansion of the biopharmaceutical industry, increased adoption of biologics, a rise in the prevalence of chronic diseases, continuous clinical advancements and drug innovation, and a heightened focus on drug delivery.

The albumin excipient market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $6.64 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.6%. Key factors contributing to this anticipated growth include ongoing expansion in biopharmaceuticals, an expanding biologics pipeline, an aging global demographic, worldwide vaccination efforts, and increased investment in drug development. Significant trends identified for this period encompass biodegradable and biocompatible characteristics, collaborative research ventures, adherence to regulatory and quality benchmarks, utility in cell therapy, and the provision of customized and bespoke solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

Which Factors And Drivers Are Influencing The Albumin Excipient Market In 2025?

The increasing occurrence of chronic illnesses is anticipated to boost the expansion of the albumin excipient market in the future. These are medical conditions persisting for three months or longer and often worsening over time. Albumin, being the most abundant circulating protein in plasma, serves as a blood volumizer and a flexible protein carrier, aiding in drug targeting and enhancing the pharmacokinetic profiles of peptide or protein-based medications, playing a role in managing various conditions like cancer and diabetes. To illustrate, in February 2024, the World Health Organization, a Switzerland-based agency of the United Nations, projected that new cancer cases would exceed 35 million by 2050. This represents a 77% surge compared to the approximately 20 million cases estimated in 2022. Consequently, the growing incidence of chronic diseases is a significant factor driving the demand within the albumin excipient market.

What Are The Major Segment Types Covered In The Albumin Excipient Market?

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin

2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:

1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin

2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

What Key Innovation Trends Are Fueling Advancements In The Albumin Excipient Market?

Key players within the albumin excipient market are increasingly utilizing strategic collaborations to cater to the critical needs of the biotechnology and pharmaceutical industries. These alliances involve companies combining their respective strengths and resources to attain shared advantages and successful outcomes. As an illustration, in October 2023, ARTES Biotechnology GmbH, a biotechnology firm from Germany, formed a partnership with Basic Pharma, a pharmaceutical company based in the Netherlands, with the goal of enhancing recombinant protein production. Through this collaboration, their objective is to improve pharmaceutical recombinant protein production by optimizing the supply chain and accelerating the introduction of new products to the market.

Which Global Market Leaders Are Shaping The Future Of The Albumin Excipient Sector?

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Which Region Is Projected To Lead The Albumin Excipient Market During The Forecast Period?

North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Albumin Excipient Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp

Browse Through More Reports Similar to the Global Albumin Excipient Market 2025, By The Business Research Company

Synthetic Biology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Digestive Enzyme Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

Specialty Enzyme Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/specialty-enzyme-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795